A Long-term Efficacy and Safety of NTQ5082 Capsules
NCT07177872 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2025-09-17
Summary
NTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, open-label study evaluating the long-term efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinuria
Conditions
Interventions
- DRUG
-
NTQ5082 capsules 200 mg
NTQ5082 capsules 200 mg
Sponsors & Collaborators
-
Nanjing Chia-tai Tianqing Pharmaceutical
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2028-06-30
- Completion
- 2028-06-30
Countries
- China
Study Locations
More Related Trials
-
Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
NCT00442871 ·Status: COMPLETED ·Phase: PHASE1
-
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
NCT06693791 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT03896152 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Hetrombopag in Healthy Subjects
NCT05088174 ·Status: COMPLETED ·Phase: PHASE1
-
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
NCT03664518 ·Status: COMPLETED ·Phase: PHASE2
-
Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease
NCT05823376 ·Status: RECRUITING
-
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia (SAA) Patient
NCT03557099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry
NCT06903234 ·Status: ACTIVE_NOT_RECRUITING
-
Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
NCT02556814 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
NCT04021173 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
NCT06838949 ·Status: RECRUITING ·Phase: PHASE2
-
Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
NCT05727917 ·Status: UNKNOWN ·Phase: NA
-
Eltrombopag Phase III Study In Chinese Chronic ITP Patients
NCT01762761 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults
NCT07083739 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Herombopag for Chemotherapy-induced Thrombocytopenia
NCT05236582 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
NCT05995054 ·Status: RECRUITING ·Phase: PHASE2
-
Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases
NCT05324917 ·Status: UNKNOWN
-
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
NCT02857530 ·Status: UNKNOWN ·Phase: PHASE2
-
Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia
NCT01719692 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy
NCT02391272 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA
NCT05333861 ·Status: NOT_YET_RECRUITING
-
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06094881 ·Status: RECRUITING ·Phase: PHASE2
-
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
NCT03201848 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP
NCT05369208 ·Status: COMPLETED ·Phase: PHASE3